Hyderabad- Based Company Gets Approval for Production of Esomol Hydrochloride Injection

by Reshma Anand on  July 28, 2015 at 12:19 PM Corporate News
RSS Email Print This Page Comment
Font : A-A+

Aurobindo Pharma Limited has received final approval to manufacture and market Esmolol Hydrochloride Injection from the US Food and Drug Administration (USFDA).
Hyderabad- Based Company Gets Approval for Production of Esomol Hydrochloride Injection
Hyderabad- Based Company Gets Approval for Production of Esomol Hydrochloride Injection

Esmolol Hydrochloride Injection, 100mg/10mL (10mg/mL) is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Brevibloc Injection, 10mg/mL of Baxter Healthcare Corporation.

It is indicated for the short-term treatment of tachycardia and hypertension that occur during induction and tracheal intubation, during surgery, on emergence from anesthesia and in the postoperative period

Aurobindo now has 13 ANDAs (represented by 10 product classes) approved out of Unit IV formulation facility in Hyderabad for manufacturing general injectable products and will be marketed and sold by Aurobindo's wholly-owned subsidiary AuroMedics Pharma LLC. The Aurobindo counter closed 0.41 percent up at Rs 738 on the BSE.



Source: PTI

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive